• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

创新手术技术早期采用的决策制定标准排名。

Ranking Decision-Making Criteria for Early Adoption of Innovative Surgical Technologies.

机构信息

Department of Experimental Surgery, Faculty of Medicine, McGill University, Montreal, Quebec, Canada.

Vanier Scholar, Canadian Institutes of Health Research.

出版信息

JAMA Netw Open. 2023 Nov 1;6(11):e2343703. doi: 10.1001/jamanetworkopen.2023.43703.

DOI:10.1001/jamanetworkopen.2023.43703
PMID:37971741
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10654796/
Abstract

IMPORTANCE

There is no decision-making framework in the early-adoption stage of novel surgical technologies, putting the quality of health care and resource allocation of the health care system at risk.

OBJECTIVE

To investigate relevant weighted criteria that decision-makers may use to make an informed decision for the early adoption of innovative surgical technologies.

DESIGN, SETTING, AND PARTICIPANTS: This multi-institutional decision analytical modeling study used a mixed-methods multicriteria decision analysis (MCDA) and had 2 phases. First, a panel of 12 experts validated decision criteria in the literature and identified additional criteria. Second, 33 Canadian experts prioritized the main criteria (domains) using the composition pairwise-comparison weight-elicitation method (analytical hierarchy process model) and ranked their subcriteria using the direct-ranking elicitation method (Likert scale). Data were analyzed, and response consistency was estimated using the consistency ratio. Analysis of variance was used to assess for significant differences between expert responses. The MCDA was conducted at McGill University between 2021 and 2023. Data were collected nationally by inviting experts in Canada.

MAIN OUTCOME AND MEASURE

Criteria domain weights and subcriteria rankings. Priority vectors, which are priority scores analyzed and prioritized from expert responses, were used to rank criteria domains and subcriteria for decision-making on adopting new innovative surgical technologies.

RESULTS

A total of 45 experts (33 male [73.3%] and 12 female [26.7%]) were invited with different levels of education (22 experts with MD or equivalent, 13 experts with master's degree, and 12 experts with PhD degree) and years of experience (4 experts with <10, 12 experts with 11-20, 18 experts with 21-30, and 11 experts with >30 years). Surgeon experts (23 individuals) were from all surgical disciplines, and nonsurgeon experts (22 individuals) were administrative officers in surgical device procurement, health technology assessment experts, and hospital directors. A total of 7 domains and 44 subcriteria were identified. The MCDA model found that clinical outcomes had the highest priority vector, at 0.429, followed by patients and public relevance (0.135). Hospital-specific criteria (priority vector, 0.099), technology-specific criteria (priority vector, 0.092), and physician-specific criteria (priority vector, 0.087) were the next most highly ranked. The lowest priority vectors were for economic criteria, at 0.083, and finally policies and procedures, at 0.075. There was consensus in the responses (consistency ratio = 0.006), and there were no statistically significant differences between expert responses.

CONCLUSIONS AND RELEVANCE

This study weighted priority criteria domains in importance and established ranked subcriteria for decision-making of early adoption of surgical technologies. Putting these criteria into a framework may help surgeons and decision-makers make informed decisions for the early adoption of new surgical technologies.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/33d0564ebcc3/jamanetwopen-e2343703-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/1d56bfb93c8b/jamanetwopen-e2343703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/6325f397c25f/jamanetwopen-e2343703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/33d0564ebcc3/jamanetwopen-e2343703-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/1d56bfb93c8b/jamanetwopen-e2343703-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/6325f397c25f/jamanetwopen-e2343703-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4f5f/10654796/33d0564ebcc3/jamanetwopen-e2343703-g003.jpg
摘要

重要性:在新型外科技术的早期采用阶段,没有决策框架,这使得医疗保健的质量和医疗保健系统的资源分配面临风险。

目的:研究决策者可能用于为创新外科技术的早期采用做出明智决策的相关加权标准。

设计、设置和参与者:本多机构决策分析模型研究使用了混合方法多准则决策分析(MCDA),并分为两个阶段。首先,一个由 12 名专家组成的小组在文献中验证了决策标准,并确定了其他标准。其次,33 名加拿大专家使用组成对比较权重 elicitation 方法(层次分析法模型)对主要标准(领域)进行优先级排序,并使用直接排序 elicitation 方法(李克特量表)对其子标准进行排名。使用一致性比率分析数据并估计响应一致性。方差分析用于评估专家响应之间是否存在显著差异。MCDA 在 2021 年至 2023 年期间在麦吉尔大学进行。通过邀请加拿大专家,在全国范围内收集数据。

主要结果和测量:标准领域权重和子标准排名。优先级向量是从专家响应中分析和优先考虑的优先级分数,用于对采用新创新外科技术进行决策的标准领域和子标准进行排名。

结果:共邀请了 45 名专家(33 名男性[73.3%]和 12 名女性[26.7%]),具有不同的教育水平(22 名专家具有医学博士或同等学历,13 名专家具有硕士学位,12 名专家具有博士学位)和工作经验(4 名专家<10 年,12 名专家 11-20 年,18 名专家 21-30 年,11 名专家>30 年)。外科医生专家(23 人)来自所有外科专业,非外科医生专家(22 人)是外科设备采购、卫生技术评估专家和医院主管。确定了 7 个领域和 44 个子标准。MCDA 模型发现临床结果的优先级向量最高,为 0.429,其次是患者和公众相关性(0.135)。医院特定标准(优先级向量,0.099)、技术特定标准(优先级向量,0.092)和医生特定标准(优先级向量,0.087)是下一个最受重视的标准。经济标准的优先级向量最低,为 0.083,最后是政策和程序,为 0.075。响应存在一致性(一致性比率=0.006),并且专家响应之间没有统计学上的显著差异。

结论和相关性:本研究对重要性标准领域进行了优先级加权,并为外科技术的早期采用制定了排名子标准。将这些标准纳入框架可能有助于外科医生和决策者为新外科技术的早期采用做出明智决策。

相似文献

1
Ranking Decision-Making Criteria for Early Adoption of Innovative Surgical Technologies.创新手术技术早期采用的决策制定标准排名。
JAMA Netw Open. 2023 Nov 1;6(11):e2343703. doi: 10.1001/jamanetworkopen.2023.43703.
2
Multicriteria decision analysis (MCDA) for health technology assessment: the Queensland Health experience.用于卫生技术评估的多标准决策分析(MCDA):昆士兰卫生部门的经验
Aust Health Rev. 2019 Oct;43(5):591-599. doi: 10.1071/AH18042.
3
Decision making for early surgical technology adoption into Canada's healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities.加拿大医疗保健系统中早期采用外科技术的决策:决策标准、挑战和机遇的范围综述。
Int J Technol Assess Health Care. 2023 Jun 19;39(1):e41. doi: 10.1017/S0266462323000363.
4
Developing a reference protocol for structured expert elicitation in health-care decision-making: a mixed-methods study.制定医疗保健决策中结构化专家 elicitation 的参考协议:混合方法研究。
Health Technol Assess. 2021 Jun;25(37):1-124. doi: 10.3310/hta25370.
5
TESTING MULTI-CRITERIA DECISION ANALYSIS FOR MORE TRANSPARENT RESOURCE-ALLOCATION DECISION MAKING IN COLOMBIA.在哥伦比亚,测试多标准决策分析以实现更透明的资源分配决策
Int J Technol Assess Health Care. 2016 Jan;32(4):307-314. doi: 10.1017/S0266462316000350. Epub 2016 Oct 3.
6
Application of Multi-Criteria Decision Analysis (MCDA) to Prioritize Real-World Evidence Studies for Health Technology Management: Outcomes and Lessons Learned by the Canadian Real-World Evidence for Value of Cancer Drugs (CanREValue) Collaboration.多准则决策分析(MCDA)在优先考虑健康技术管理的真实世界证据研究中的应用:加拿大癌症药物价值真实世界证据(CanREValue)合作的结果和经验教训。
Curr Oncol. 2024 Apr 1;31(4):1876-1898. doi: 10.3390/curroncol31040141.
7
Bridging health technology assessment (HTA) and efficient health care decision making with multicriteria decision analysis (MCDA): applying the EVIDEM framework to medicines appraisal.将健康技术评估(HTA)与多准则决策分析(MCDA)相结合,以实现高效的医疗保健决策:将 EVIDEM 框架应用于药品评估。
Med Decis Making. 2012 Mar-Apr;32(2):376-88. doi: 10.1177/0272989X11416870. Epub 2011 Oct 10.
8
Improving Hospital Based Medical Procurement Decisions with Health Technology Assessment and Multi-Criteria Decision Analysis.利用健康技术评估和多准则决策分析改进医院的医疗采购决策。
Inquiry. 2021 Jan-Dec;58:469580211022911. doi: 10.1177/00469580211022911.
9
Bridging health technology assessment (HTA) with multicriteria decision analyses (MCDA): field testing of the EVIDEM framework for coverage decisions by a public payer in Canada.将卫生技术评估 (HTA) 与多准则决策分析 (MCDA) 相结合:在加拿大,对公共支付方进行覆盖决策的 EVIDEM 框架进行现场测试。
BMC Health Serv Res. 2011 Nov 30;11:329. doi: 10.1186/1472-6963-11-329.
10
Multicriteria decision analysis process to develop new classification criteria for systemic lupus erythematosus.多准则决策分析过程制定系统性红斑狼疮的新分类标准。
Ann Rheum Dis. 2019 May;78(5):634-640. doi: 10.1136/annrheumdis-2018-214685. Epub 2019 Jan 28.

引用本文的文献

1
Correspondence: "Pencil cleaning technique for robotic liver parenchymal transection: a step further to systematization beyond the microfracture‑coagulation method".通信:“机器人肝脏实质横断术的铅笔清洁技术:超越微骨折-凝固法向系统化迈进的一步”
J Robot Surg. 2025 Aug 13;19(1):480. doi: 10.1007/s11701-025-02664-z.
2
Impact of metal vs non-absorbable, polymer clips during laparoscopic cholecystectomy.腹腔镜胆囊切除术期间金属夹与不可吸收聚合物夹的影响
Surg Endosc. 2025 Apr;39(4):2288-2295. doi: 10.1007/s00464-025-11559-x. Epub 2025 Feb 12.
3
Advancing minimally invasive hepato-pancreato-biliary surgery: barriers to adoption and equitable access.

本文引用的文献

1
Decision making for early surgical technology adoption into Canada's healthcare system: a scoping review of the decision-making criteria, challenges, and opportunities.加拿大医疗保健系统中早期采用外科技术的决策:决策标准、挑战和机遇的范围综述。
Int J Technol Assess Health Care. 2023 Jun 19;39(1):e41. doi: 10.1017/S0266462323000363.
2
Hospital Value Committees: The Role of the Surgeon in New Technology Adoption.医院价值委员会:外科医生在新技术采用中的作用。
Surg Innov. 2021 Aug;28(4):401-402. doi: 10.1177/15533506211031094. Epub 2021 Jul 19.
3
A Framework for Aiding the Translation of Scientific Evidence into Policy: The Experience of a Hospital-Based Technology Assessment Unit.
推进微创肝胆胰手术:采用障碍和公平获取。
Surg Endosc. 2024 Oct;38(10):5643-5650. doi: 10.1007/s00464-024-11078-1. Epub 2024 Aug 8.
4
Early Impressions and Adoption of the AtriAmp for Managing Arrhythmias Following Congenital Heart Surgery.先天性心脏病手术后使用AtriAmp治疗心律失常的早期印象与应用情况
Pediatr Cardiol. 2025 Aug;46(6):1592-1599. doi: 10.1007/s00246-024-03573-y. Epub 2024 Jul 6.
5
Advancing minimally invasive hepato-pancreato-biliary surgery: ensuring safety with implementation.推进微创肝胰胆手术:实施中的安全保障。
Surg Endosc. 2024 Aug;38(8):4365-4373. doi: 10.1007/s00464-024-10957-x. Epub 2024 Jun 17.
科学证据转化为政策的辅助框架:医院技术评估单位的经验。
Int J Technol Assess Health Care. 2019 Jan;35(3):204-211. doi: 10.1017/S0266462319000254. Epub 2019 Apr 24.
4
The Role of the FDA in Ensuring the Safety and Efficacy of Artificial Intelligence Software and Devices.美国食品药品监督管理局在确保人工智能软件和设备的安全性与有效性方面所发挥的作用。
J Am Coll Radiol. 2019 Feb;16(2):208-210. doi: 10.1016/j.jacr.2018.09.007. Epub 2018 Oct 30.
5
Adoption of Robot-Assisted Partial Nephrectomies: A Population-Based Analysis of U.S. Surgeons from 2004 to 2013.机器人辅助部分肾切除术的应用:基于2004年至2013年美国外科医生的人群分析。
J Endourol. 2017 Sep;31(9):886-892. doi: 10.1089/end.2017.0174. Epub 2017 Aug 11.
6
Using health technology assessment to assess the value of new medicines: results of a systematic review and expert consultation across eight European countries.利用健康技术评估来评估新药的价值:在八个欧洲国家进行的系统评价和专家咨询的结果。
Eur J Health Econ. 2018 Jan;19(1):123-152. doi: 10.1007/s10198-017-0871-0. Epub 2017 Mar 16.
7
Challenges in the Assessment of Medical Devices: The MedtecHTA Project.医疗器械评估中的挑战:MedtecHTA项目
Health Econ. 2017 Feb;26 Suppl 1:5-12. doi: 10.1002/hec.3469.
8
Multiple Criteria Decision Analysis for Health Care Decision Making--Emerging Good Practices: Report 2 of the ISPOR MCDA Emerging Good Practices Task Force.用于医疗保健决策的多标准决策分析——新兴良好实践:ISPOR多标准决策分析新兴良好实践工作组报告2
Value Health. 2016 Mar-Apr;19(2):125-37. doi: 10.1016/j.jval.2015.12.016. Epub 2016 Mar 7.
9
Combining multi-criteria decision analysis and mini-health technology assessment: A funding decision-support tool for medical devices in a university hospital setting.结合多标准决策分析与小型健康技术评估:大学医院环境下医疗器械的资金决策支持工具。
J Biomed Inform. 2016 Feb;59:201-8. doi: 10.1016/j.jbi.2015.12.002. Epub 2015 Dec 15.
10
Barriers to medical device innovation.医疗设备创新的障碍。
Med Devices (Auckl). 2014 Jun 13;7:205-9. doi: 10.2147/MDER.S43369. eCollection 2014.